Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 247

1.

Long noncoding RNA high expression in hepatocellular carcinoma facilitates tumor growth through enhancer of zeste homolog 2 in humans.

Yang F, Zhang L, Huo XS, Yuan JH, Xu D, Yuan SX, Zhu N, Zhou WP, Yang GS, Wang YZ, Shang JL, Gao CF, Zhang FR, Wang F, Sun SH.

Hepatology. 2011 Nov;54(5):1679-89. doi: 10.1002/hep.24563. Epub 2011 Sep 6.

PMID:
21769904
2.

Long noncoding RNAs in hepatitis B virus-related hepatocellular carcinoma.

Yu TT, Xu XM, Hu Y, Deng JJ, Ge W, Han NN, Zhang MX.

World J Gastroenterol. 2015 Jun 21;21(23):7208-17. doi: 10.3748/wjg.v21.i23.7208.

3.

Long noncoding RNAs: Novel insights into hepatocelluar carcinoma.

He Y, Meng XM, Huang C, Wu BM, Zhang L, Lv XW, Li J.

Cancer Lett. 2014 Mar 1;344(1):20-27. doi: 10.1016/j.canlet.2013.10.021. Epub 2013 Oct 30. Review.

PMID:
24183851
4.

Enhancer of zeste homolog 2 epigenetically silences multiple tumor suppressor microRNAs to promote liver cancer metastasis.

Au SL, Wong CC, Lee JM, Fan DN, Tsang FH, Ng IO, Wong CM.

Hepatology. 2012 Aug;56(2):622-31. doi: 10.1002/hep.25679. Epub 2012 Jun 11.

PMID:
22370893
5.
6.

Long noncoding RNA-EBIC promotes tumor cell invasion by binding to EZH2 and repressing E-cadherin in cervical cancer.

Sun NX, Ye C, Zhao Q, Zhang Q, Xu C, Wang SB, Jin ZJ, Sun SH, Wang F, Li W.

PLoS One. 2014 Jul 9;9(7):e100340. doi: 10.1371/journal.pone.0100340. eCollection 2014.

7.

Expression profile of altered long non-coding RNAs in patients with HBV-associated hepatocellular carcinoma.

Pan YF, Qin T, Feng L, Yu ZJ.

J Huazhong Univ Sci Technolog Med Sci. 2013 Feb;33(1):96-101. doi: 10.1007/s11596-013-1078-y. Epub 2013 Feb 8.

PMID:
23392715
8.

MiR-214 targets β-catenin pathway to suppress invasion, stem-like traits and recurrence of human hepatocellular carcinoma.

Xia H, Ooi LL, Hui KM.

PLoS One. 2012;7(9):e44206. doi: 10.1371/journal.pone.0044206. Epub 2012 Sep 4. Erratum in: PLoS One. 2012;7(9). doi:10.1371/annotation/1be2a62e-45a1-4c13-9a8d-f265005a21e0.

9.

High expression of long non-coding RNA ANRIL is associated with poor prognosis in hepatocellular carcinoma.

Hua L, Wang CY, Yao KH, Chen JT, Zhang JJ, Ma WL.

Int J Clin Exp Pathol. 2015 Mar 1;8(3):3076-82. eCollection 2015.

10.
11.

MicroRNA-101 inhibits human hepatocellular carcinoma progression through EZH2 downregulation and increased cytostatic drug sensitivity.

Xu L, Beckebaum S, Iacob S, Wu G, Kaiser GM, Radtke A, Liu C, Kabar I, Schmidt HH, Zhang X, Lu M, Cicinnati VR.

J Hepatol. 2014 Mar;60(3):590-8. doi: 10.1016/j.jhep.2013.10.028. Epub 2013 Nov 6.

PMID:
24211739
12.

Lentivirus-mediated RNA interference targeting enhancer of zeste homolog 2 inhibits hepatocellular carcinoma growth through down-regulation of stathmin.

Chen Y, Lin MC, Yao H, Wang H, Zhang AQ, Yu J, Hui CK, Lau GK, He ML, Sung J, Kung HF.

Hepatology. 2007 Jul;46(1):200-8. Erratum in: Hepatology. 2007 Oct;46(4):1314.

PMID:
17596871
13.

lncRNA Up-Regulated in Nonmuscle Invasive Bladder Cancer Facilitates Tumor Growth and Acts as a Negative Prognostic Factor of Recurrence.

Zhang S, Zhong G, He W, Yu H, Huang J, Lin T.

J Urol. 2016 Oct;196(4):1270-8. doi: 10.1016/j.juro.2016.05.107. Epub 2016 Jun 5.

PMID:
27267320
14.

PKCalpha mediated induction of miR-101 in human hepatoma HepG2 cells.

Chiang CW, Huang Y, Leong KW, Chen LC, Chen HC, Chen SJ, Chou CK.

J Biomed Sci. 2010 May 6;17:35. doi: 10.1186/1423-0127-17-35.

15.

Long non-coding RNA TUG1 is up-regulated in hepatocellular carcinoma and promotes cell growth and apoptosis by epigenetically silencing of KLF2.

Huang MD, Chen WM, Qi FZ, Sun M, Xu TP, Ma P, Shu YQ.

Mol Cancer. 2015 Sep 4;14:165. doi: 10.1186/s12943-015-0431-0.

16.

Identification of long noncoding RNA expression profile in oxaliplatin-resistant hepatocellular carcinoma cells.

Yin X, Zheng SS, Zhang L, Xie XY, Wang Y, Zhang BH, Wu W, Qiu S, Ren ZG.

Gene. 2017 Jan 5;596:53-88. doi: 10.1016/j.gene.2016.10.008. Epub 2016 Oct 8.

PMID:
27729273
17.

Histone-modifying genes as biomarkers in hepatocellular carcinoma.

Hung SY, Lin HH, Yeh KT, Chang JG.

Int J Clin Exp Pathol. 2014 Apr 15;7(5):2496-507. eCollection 2014.

18.

Investigation of long noncoding RNAs expression profile as potential serum biomarkers in patients with hepatocellular carcinoma.

Kamel MM, Matboli M, Sallam M, Montasser IF, Saad AS, El-Tawdi AHF.

Transl Res. 2016 Feb;168:134-145. doi: 10.1016/j.trsl.2015.10.002. Epub 2015 Oct 24.

PMID:
26551349
19.

CLDN14 is epigenetically silenced by EZH2-mediated H3K27ME3 and is a novel prognostic biomarker in hepatocellular carcinoma.

Li CP, Cai MY, Jiang LJ, Mai SJ, Chen JW, Wang FW, Liao YJ, Chen WH, Jin XH, Pei XQ, Guan XY, Zeng MS, Xie D.

Carcinogenesis. 2016 Jun;37(6):557-566. doi: 10.1093/carcin/bgw036. Epub 2016 Mar 31.

PMID:
27207647
20.

Long non-coding RNA expression profiles of hepatitis C virus-related dysplasia and hepatocellular carcinoma.

Zhang H, Zhu C, Zhao Y, Li M, Wu L, Yang X, Wan X, Wang A, Zhang MQ, Sang X, Zhao H.

Oncotarget. 2015 Dec 22;6(41):43770-8. doi: 10.18632/oncotarget.6087.

Supplemental Content

Support Center